Strategies for Targeting the Multidrug Resistance-1 (MDR1)/P-gp Transporter in Human Malignancies

By  

Current Cancer Drug Targets, Vol. 5, Iss. 6, 2005-09 ,pp. : 445-455

Bentham Science Publishers

Access to resources Recommend Favorite

(Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) ATP Hydrolysis-Dependent Multidrug Efflux Transporter: MDR1 / Pglycoprotein

By  

Current Drug Metabolism, Vol. 5, Iss. 1, 2004-02 ,pp. : 1-10

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs

By Sakaeda Toshiyuki   Nakamura Tsutomu   Okumura Katsuhiko  

Pharmacogenomics, Vol. 4, Iss. 4, 2003-07 ,pp. : 397-410

Future Medicine

Access to resources Recommend Favorite

MDR1/ABCB1 polymorphisms and multidrug resistance in epilepsy: in and out of fashion

By Lööscher Wolfgang   Delanty Norman  

Pharmacogenomics, Vol. 10, Iss. 5, 2009-05 ,pp. : 711-713

Future Medicine

Access to resources Recommend Favorite

Effects of 12 Ca 2+ antagonists on multidrug resistance, MDR1-mediated transport and MDR1 mRNA expression

By Takara K.   Sakaeda T.   Tanigawara Y.   Nishiguchi K.   Ohmoto N.   Horinouchi M.   Komada F.   Ohnishi N.   Yokoyama T.   Okumura K.  

European Journal of Pharmaceutical Sciences, Vol. 16, Iss. 3, 2002-08 ,pp. : 159-165

Elsevier

Access to resources Recommend Favorite